This inventor holds 1 USPTO granted patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Miki Shokyo: Innovator in Pharmaceutical Chemistry
Introduction
Miki Shokyo is a notable inventor based in Toyonaka, Japan. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for producing complex chemical compounds. Her work is recognized for its industrial advantages and potential applications in medicine.
Latest Patents
Miki Shokyo holds a patent for a process for producing a fused imidazole compound, specifically a Reformatsky reagent in stable form. This invention provides an industrially advantageous method for producing a steroid Clyase inhibitor represented by the general formula (I). The patent highlights her innovative approach to chemical synthesis, which can have important implications in drug development.
Career Highlights
Shokyo is currently employed at Takeda Pharmaceutical Company Limited, a leading global pharmaceutical company. Her role involves research and development, where she applies her expertise in chemistry to advance pharmaceutical innovations. Her contributions have been instrumental in enhancing the company's product offerings and research capabilities.
Collaborations
Miki Shokyo has collaborated with esteemed colleagues, including Jun-Ichi Kawakami and Shigeru Nuwa. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further driving innovation in their projects.
Conclusion
Miki Shokyo's work exemplifies the impact of innovative thinking in the pharmaceutical industry. Her patent and contributions to Takeda Pharmaceutical Company Limited underscore her role as a key figure in advancing chemical processes for medical applications.